A prospective, randomized, open-label, controlled study evaluating the efficacy and safety of fluvastatin on telaprevir-based combination therapy for patients with chronic hepatitis C genotype 1b infection.

Trial Profile

A prospective, randomized, open-label, controlled study evaluating the efficacy and safety of fluvastatin on telaprevir-based combination therapy for patients with chronic hepatitis C genotype 1b infection.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Dec 2015

At a glance

  • Drugs Fluvastatin (Primary) ; Peginterferon alfa; Ribavirin; Telaprevir
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top